GlassScriptPhysician profile
Marta Uhlyar
NPI 1710410006
$2,076.25
in general payments reported to CMS, 2019-2025
17 companies · $782 in 2025
The $782 reported for 2025 was more than what 81% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $196 · 2022: $38.48 · 2023: $286 · 2024: $774 · 2025: $782.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,407 · Education: $435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,407.02 |
| Education | $434.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $490.39 | 2023-2025 | Cresemba |
| Janssen Biotech, INC. | $423.62 | 2024-2025 | Carvykti, Rybrevant |
| Janssen Scientific Affairs, LLC | $181.19 | 2022-2024 | Darzalex |
| Abbvie INC. | $125.10 | 2024 | |
| Btg International INC. | $123.95 | 2025 | Voraxaze |
| Gilead Sciences, INC. | $115.34 | 2024 | Trodelvy |
| Servier Pharmaceuticals LLC | $112.33 | 2025 | |
| Amgen INC. | $110.82 | 2021-2022 | |
| Kite Pharma, INC. | $100.00 | 2021 | |
| Seagen INC. | $93.00 | 2023 | Adcetris |
| Novartis Pharmaceuticals Corporation | $70.31 | 2025 | |
| Sobi, INC | $36.40 | 2024 | |
| Incyte Corporation | $22.08 | 2025 | Jakafi |
| Blueprint Medicines Corporation | $20.65 | 2025 | Ayvakit |
| Geron Corporation | $18.75 | 2025 | Rytelo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $18.23 | 2023 | |
| Pharmacyclics LLC, An Abbvie Company | $14.09 | 2023 | Epkinly |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marta Uhlyar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.